Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Mepolizumab.

Client Email

Product

Mepolizumab
HEALTH CANADA PATENTS

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Mepolizumab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 Listed Suppliers

2 API Suppliers
2 Listed Suppliers

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 2 FDA Orange Book, 5 Europe, 3 Canada, 8 Australia

18 FDF Dossiers
2 FDA Orange Book
5 Europe
3 Canada
8 Australia

RELATED EXCIPIENT COMPANIES

1 Jai Radhe Sales, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Actylis, 1 BASF, 4 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic

1 Jai Radhe Sales
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
3 Actylis
1 BASF
4 Gangwal Chemicals
1 Nanjing Bold Chemical
6 Seppic

EXCIPIENTS BY APPLICATIONS

10 Solubilizers, 6 Parenteral, 4 Thickeners and Stabilizers, 3 Emulsifying Agents, 3 Topical, 2 Taste Masking, 2 Surfactant & Foaming Agents, 2 Coating Systems & Additives, 2 Film Formers & Plasticizers, 1 Co-Processed Excipients, 1 Direct Compression, 1 Rheology Modifiers, 1 API Stability Enhancers

10 Solubilizers
6 Parenteral
4 Thickeners and Stabilizers
3 Emulsifying Agents
3 Topical
2 Taste Masking
2 Surfactant & Foaming Agents
2 Coating Systems & Additives
2 Film Formers & Plasticizers
1 Co-Processed Excipients
1 Direct Compression
1 Rheology Modifiers
1 API Stability Enhancers

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 77 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
77 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices, 8 Annual Reports

1 US Medicaid Prescriptions
4 Finished Drug Prices
8 Annual Reports

MARKET PLACE

1 APIs, 1 FDF Dossiers

1 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1GlaxoSmithKline Inc.

filter Patent Reset all filters

1 All

01 12208503

filter Product Reset all filters

1 All

01 1MEPOLIZUMAB

filter Dosage Reset all filters

1 All

01 1POWDER FOR SOLUTION

filter Exp Date Reset all filters

1 All

01 12015-12-22

Product Main Page

01

GlaxoSmithKline Inc.

Mepolizumab

Luxepack

Not Confirmed

GlaxoSmithKline Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-12-22

Date Granted : 2009-12-01

Mepolizumab

Brand Name : NUCALA

Patent Number : 2208503

Filing Date : 1995-12-22

Strength per Unit : 100 mg / mL

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2015-12-22

Date Granted : 2009-12-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?